Cheng Zhao

Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Clinical characteristics, treatment and prognostic influencing factors in patients with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody

Clinical characteristics, treatment and prognostic influencing factors in patients with dermatomyositis positive for anti-melanoma differentiation-associated gene 5 antibody

Journal: Zhonghua nei ke za zhi

Published: August 05, 2026

Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.

Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.

Journal: JAMA network open

Published: May 08, 2026

The role of IRF-1 in mediating T-cell immune imbalance in systemic lupus erythematosus and the construction of a diagnostic model.

The role of IRF-1 in mediating T-cell immune imbalance in systemic lupus erythematosus and the construction of a diagnostic model.

Journal: Autoimmunity

Published: November 20, 2025

Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort Study.

Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort Study.

Journal: MedComm

Published: June 09, 2025

Effectiveness and safety of tacrolimus in systemic lupus erythematosus with various clinical manifestations: a retrospective real-world study.

Effectiveness and safety of tacrolimus in systemic lupus erythematosus with various clinical manifestations: a retrospective real-world study.

Journal: Arthritis research & therapy

Published: May 07, 2025

Repeat renal biopsy findings in 82 lupus nephritis patients: a clinicopathological study.

Repeat renal biopsy findings in 82 lupus nephritis patients: a clinicopathological study.

Journal: International journal of clinical and experimental pathology

Published: April 29, 2025

Tofacitinib Versus Methotrexate in Treating Mucocutaneous and Musculoskeletal Lesions of Systemic Lupus Erythematosus: Real-World Results From the CSTAR Cohort XXXII.

Tofacitinib Versus Methotrexate in Treating Mucocutaneous and Musculoskeletal Lesions of Systemic Lupus Erythematosus: Real-World Results From the CSTAR Cohort XXXII.

Journal: International journal of rheumatic diseases

Published: January 06, 2025

Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial.

Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 03, 2025

Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study.

Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study.

Journal: Lupus

Published: September 12, 2024

Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII.

Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII.

Journal: Lupus

Published: August 09, 2024

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes.

Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes.

Journal: BMC medicine

Published: July 02, 2024

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Journal: Clinical rheumatology

Published: May 29, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026